Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Askling

Showing results (31-40 of 345) with videos related to

Pageof 35
Sort By:
Annals of the Rheumatic Diseases|October 9, 2020
Risk of venous thromboembolism in rheumatoid arthritis, and its association with disease activity: a nationwide cohort study from SwedenViktor Molander, Hannah Bower, Thomas Frisell, et al.
Annals of the Rheumatic Diseases|January 13, 2016
Do RA or TNF inhibitors increase the risk of cervical neoplasia or of recurrence of previous neoplasia? A nationwide study from SwedenHjalmar Wadström, Thomas Frisell, Pär Sparén, et al.
Arthritis Care & Research|April 21, 2015
Consistency and Utility of Data Items Across European Rheumatoid Arthritis Clinical Cohorts and RegistersHelga Radner, William Dixon, Kimme Hyrich, et al.
Rheumatology (Oxford, England)|October 16, 2024
Impact of incident rheumatoid arthritis on earnings: a nationwide sibling comparison studyHeather Miller, Martin Neovius, Johan Askling, et al.
Annals of the Rheumatic Diseases|February 18, 2025
Do newly approved drugs have a worse observed safety profile than once established? A study on time trends in risks of key safety outcomes with immunomodulatory drugs against rheumatoid arthritisViktor Molander, Hannah Bower, Thomas Frisell, et al.
Lakartidningen|February 22, 2013
[Observational cohort studies. Overview and some examples from the field of drug safety]Marie Holmqvist, Pauline Raaschou, Martin Neovius, et al.
Annals of Internal Medicine|August 15, 2018
Tumor Necrosis Factor Inhibitors and Cancer Recurrence in Swedish Patients With Rheumatoid Arthritis: A Nationwide Population-Based Cohort StudyPauline Raaschou, Jonas Söderling, Carl Turesson, et al.
Annals of the Rheumatic Diseases|July 1, 2017
Juvenile onset arthritis and pregnancy outcome: a population-based cohort studyKatarina Remaeus, Kari Johansson, Johan Askling, et al.
ACR Open Rheumatology|May 12, 2023
Risk of Psychiatric Disorders in Juvenile Idiopathic Arthritis: Population- and Sibling-Controlled Cohort and Cross-Sectional AnalysesBénédicte Delcoigne, AnnaCarin Horne, Johan Reutfors, et al.
RMD Open|July 17, 2020
Gastrointestinal perforations in patients with rheumatoid arthritis treated with biological disease-modifying antirheumatic drugs in Sweden: a nationwide cohort studyAndrei Barbulescu, Bénédicte Delcoigne, Johan Askling, et al.
Pageof 35

Showing results (31-40 of 345) with videos related to

Sort By:
Pageof 35
Annals of the Rheumatic Diseases|October 9, 2020
Risk of venous thromboembolism in rheumatoid arthritis, and its association with disease activity: a nationwide cohort study from SwedenViktor Molander, Hannah Bower, Thomas Frisell, et al.
Annals of the Rheumatic Diseases|January 13, 2016
Do RA or TNF inhibitors increase the risk of cervical neoplasia or of recurrence of previous neoplasia? A nationwide study from SwedenHjalmar Wadström, Thomas Frisell, Pär Sparén, et al.
Arthritis Care & Research|April 21, 2015
Consistency and Utility of Data Items Across European Rheumatoid Arthritis Clinical Cohorts and RegistersHelga Radner, William Dixon, Kimme Hyrich, et al.
Rheumatology (Oxford, England)|October 16, 2024
Impact of incident rheumatoid arthritis on earnings: a nationwide sibling comparison studyHeather Miller, Martin Neovius, Johan Askling, et al.
Annals of the Rheumatic Diseases|February 18, 2025
Do newly approved drugs have a worse observed safety profile than once established? A study on time trends in risks of key safety outcomes with immunomodulatory drugs against rheumatoid arthritisViktor Molander, Hannah Bower, Thomas Frisell, et al.
Lakartidningen|February 22, 2013
[Observational cohort studies. Overview and some examples from the field of drug safety]Marie Holmqvist, Pauline Raaschou, Martin Neovius, et al.
Annals of Internal Medicine|August 15, 2018
Tumor Necrosis Factor Inhibitors and Cancer Recurrence in Swedish Patients With Rheumatoid Arthritis: A Nationwide Population-Based Cohort StudyPauline Raaschou, Jonas Söderling, Carl Turesson, et al.
Annals of the Rheumatic Diseases|July 1, 2017
Juvenile onset arthritis and pregnancy outcome: a population-based cohort studyKatarina Remaeus, Kari Johansson, Johan Askling, et al.
ACR Open Rheumatology|May 12, 2023
Risk of Psychiatric Disorders in Juvenile Idiopathic Arthritis: Population- and Sibling-Controlled Cohort and Cross-Sectional AnalysesBénédicte Delcoigne, AnnaCarin Horne, Johan Reutfors, et al.
RMD Open|July 17, 2020
Gastrointestinal perforations in patients with rheumatoid arthritis treated with biological disease-modifying antirheumatic drugs in Sweden: a nationwide cohort studyAndrei Barbulescu, Bénédicte Delcoigne, Johan Askling, et al.
Pageof 35